Abstract: Only few follow-up studies have studied in detail the role of most important risk factors, but no reports were found on critical values (cut-offs) for such factors in prospectively predicting cerebrovascular events (CVE) in patients with minor ischaemic stroke (MIS). Estimates of predictive importance of such cut-offs may better inform and contribute to optimize treatment. This was a post-hoc modelling study with unique data from Bulgaria on 54 consecutive patients with MIS, aged ł 40, followed for 12 months for nonfatal or fatal CV events. A set of routine clinical demographic and known risk factors (SBP, DBP, HDL cholesterol, etc.) were explored using univariate statistics and multivariate regression models to identify the most important independent predictors of secondary CVE. An artificial neural network (ANN) model, irrespective of usual statistical constraints, also confirmed the specific role and importance of identified predictors. A receiver operating characteristics (ROC) curve and stratified survival analyses were used to define the best cut-off of most important predictors and validate the final model. .79, 95%CI 0.60¸0.99, p=0.009) for CV events in patients with MIS has been found. In conclusions the new DBP cut-off (sensitivity>87%, specificity>69%) clearly discriminated between absence and presence of secondary CVE as also confirmed by stratified survival analysis (7 vs. 1 events, p logrank =0.0103). This cut-off may be applied to better precisely evaluate and define, as earlier as possible, MIS patients at increased risk of secondary CV events.
Introduction
The cerebrovascular (CV) events have come to represent one of the most important socio-economic burdens to public health during recent decades. CV events (CVE) share common risk factors and sequels leading to significant morbidity and mortality [1] [2] [3] . These events consist mainly of nonfatal or fatal ischaemic or haemorrhagic stroke. The former also includes minor ischemic stroke (MIS). Knowing the risk of further cerebrovascular events in patients with MIS is of great importance to clinical decision-making concerning diagnostic testing, cost-effective treatment, and secondary preventive measures. To note, identifying early increased risk for secondary CVE allows specific and early interventions to be planned. Moreover, cerebrovascular events are important predictors of outcomes after MIS [4, 5] and may be a better early proxy of therapeutic effects than mortality in stroke trials [6] . It is very important to better understand the risk of cerebrovascular events after MIS, but few studies have provided detailed results on the most important risk factors and their critical values (cut-offs) at baseline in such patients, while none have provided such data from Bulgaria. To note, our recent study [7] has provided evidence on 3-year dynamics and patterns of increasing risk for major vascular events (including CVE) in MIS patients from Bulgaria. However, even our own works [8, 9] , when having described the CVE survival and patterns of risk factors in MIS patients, have neither reported detailed analysis of these risk factors nor any putative critical (cut-off) values.
Our hypothesis was that MIS patients may show different prognosis in the view of subsequent cerebrovascular events (e.g., in comparison with transient ischaemic attacks), based on different dominating pathogenic mechanisms, such as a local formation of thrombi and/or previous vascular damage. Thus, defining a critical (cut-off) value for independent predictors of secondary CVE in MIS patients may not only be of practical value but may also elucidate the role of such predictors and their relative importance in risk determination as well as provide further evidence on the above pathological mechanisms. Therefore, in this post-hoc modelling study, we (i) determined and ordered the most important independent risk factors for CVE; (ii) quantified odds ratios; and (iii) revealed and validated the best cut-off (critical) value for the diastolic blood pressure in predicting the risk of nonfatal or fatal cerebrovascular risk after MIS over a relatively long period of 12-month follow-up on data from Bulgaria. The results of this modelling approach formed the basis of the present report.
Material and Methods

Patient selection, diagnosis, data collection, and main characteristics
The Plovdiv project included hospital-based incident vascular events cohort study designed to determine predictors of incidence and prognosis of vascular events (including initial index events as well as the recurrence of cerebro-and cardiovascular events) from a hospitalized population [7] [8] [9] [10] .
Our main hypothesis and the methods of patient identification and enrolment have been described earlier [8] [9] [10] . In particular, patients with cerebrovascular disease had been hospitalized in the Clinic of Cerebrovascular Diseases (Plovdiv Healthcare Region) and 68 consecutive patients with MIS were subjected to screening. All screened, eligible patients with MIS as an initial index event who provided a written, informed consent in accordance with the Declaration of Helsinki guidelines at discharge were immediately enrolled. During the lag interval from the index event until discharge (i.e., during the hospital stay), no vascular events were observed among the 56 screened, eligible patients. Of these eligible patients, 54 patients (96.4%) provided written, informed consent and were included in the current follow-up study. The other 2 eligible patients did not provide informed consent at discharge and were 
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Diastolic blood pressure cut-off predicts major cerebrovascular events after minor ischaemic stroke: a post-hoc modelling study not enrolled (Figure 1 ). The inclusion criteria were: patients with first MIS, age > 40 years, and residence in Plovdiv for at least three months before identification and enrolment [7] [8] [9] [10] . All evaluations were performed at the Medical University Hospital of Plovdiv, Bulgaria. The University Ethical Committee approved the study protocol. Data were collected by instructed physicians, while clinical (physical and neurological) examinations were conducted by study neurologists [8, 9] . The assessments covered: hypertension, diabetes, hypercholesterolemia, peripheral vascular disease, cardiac conditions, cigarette smoking, educational background, etc. A dedicated questionnaire survey, as successfully reported and used earlier [8, 9, 11] , was applied for collection of data on presence/absence of known and most frequent cerebrovascular risk factors (e.g., arterial hypertension, smoking, dyslipidemia, previous heart diseases).
Initial stroke severity was assessed using the modified Rankin Scale [12] . MIS diagnostic evaluations included CT or MRI of the brain and ultrasound evaluation and/ or trans-thoracic or trans-oesophageal echocardiogram, as appropriate. A panel of stroke neurologists assessed every CV events subtype using standard diagnostic criteria and all available information for each patient. For this study, MIS was defined as a minor stroke if the score using the modified Rankin Scale was 1 at the first evaluation, or if the score was 0 or 1 at one-month follow-up (i.e., no symptoms, or minor symptoms that did not interfere with normal lifestyle) [8] [9] [10] . In particular, acute onset was observed in 11 patients (20.4%). Extra-cranial ultrasound findings were recorded in 11 patients (20.4%). The main characteristics of the study cohort were as follows: 37 men (68.5%) and 17 women (31.5%), with male predominance in CV events (n=8 men) but with similar ages of 61.1±12.6 years in patients with CVE versus 62.2±9.2 years in patients without CVE (p>0.05). The mean follow-up time was 11.1±2.4 months with mean time to CV events of 5.8±2.7 months.
Assessment of outcome
The main outcome was defined as presence/absence of non-fatal or fatal CV event after MIS. Thus, 2 sub-categories for each outcome were established as events classification: (i) non-fatal CVE; (ii) fatal CVE. Strict evaluations were conducted at 4 visits (at baseline, month 1, month 3, and month 12) with telephone interview every other month, till month 12. Every evaluation was carried-out by contact with the patient, their family member or caregiver. Information was collected on vital and functional status, intercurrent symptoms, illness or hospitalization. The inperson visits were conducted at our clinic and included measuring vital signs from physical and neurological examination. A registry reporting system was used to identify study participants who experienced nonfatal or fatal vascular events, related hospitalization or death. All records were reviewed for all outcome events, including death, and have been maintained. All outcome events were reviewed by a neurology specialist while nonfatal strokes were validated by a study neurologist, with all deaths to be validated, as well. Deaths were to be recorded using death certificates and medical records.
Cause of death (fatal outcome) was defined as to be a result of stroke if there was clear documentation of a stroke from the death certificate or hospital records; deaths that would have occurred more than 30 days after the initial accident (i.e., secondary CV event) had to be considered related to the event on the grounds of a clinical judgment that relied on a clearly documented relationship to the stroke or its complications to the point of death in the medical records. Following the ascertainment procedures, all above mentioned death notifications, certificates, and autopsy protocols for all cases had to be collected and reviewed individually, especially for patients who died outside the hospital. In cases in which it was difficult to determine whether death was due to stroke, consensus was reached after discussion using the best available information.
Sample size estimation
The sample size of the follow-up cohort was calculated on the basis of the expected number of CV events. Assuming a theoretical distribution from 0 to 50% for the non-events and based on the 3-year cumulative incidence of 24.5% for cerebrovascular events in MIS patients from our previous study [7] , 8.16% of CV events was expected at 12 months. Thus, it was estimated that to give the study >95% power to detect such minimum event rate as statistically significant at p<0.05, 51 patients had to be included and analysed. A preliminary estimate of the prevalence of MIS patients that would satisfy the inclusion/exclusion criteria of the study from all those referred to the Clinic of Cerebrovascular Diseases yearly indicated that 56 patients with MIS should be identified throughout a screening period of about 12 months (estimated maximum 10% drop-out).
Statistical analysis
The main endpoint was codified as "outcome" (secondary CV event) (Figure 1 ). Mean ± standard deviation (S.D.) or median (IQ range) for continuous variables and proportions for categorical variables were given with two-tailed parametric (t-test, etc.) or nonparametric (chi-square, Mann-Whitney, etc.) tests at p<0.05 as appropriate, unless stated otherwise. Logistic regression modelling, as successfully applied earlier [11] [12] [13] , was used to analyse the risk factor influence and independence. These were later explored and confirmed by probabilistic artificial neural network (ANN) modelling, irrespectively of usual statistical constraints (Figure 2 ). According to their relative importance for the probability of outcome in the ANN model (event = occurrence of secondary CVE), these variables were considered for further analysis. To note, ANN was based on the feed-forward back-propagation supervised architecture with normal-cumulative-delta learning rule and sigmoid transfer (activation) function. The best network was created and trained with a built-in algorithm for dynamic addition of new hidden layers or nodes when the average error of learning was increasing by more than 0.1% (see Figure 2A) . The initial learning rate was set at 1.0 while the momentum was set at 0.8. The relative importance of input factors, with respect to the CV events, was calculated using the sum of the absolute values of the connection weights from each input node to the nodes of the next layer. The stopping rule of learning was assumed when a state of maximum overall correctness of prediction with minimum average learning error was reached [14] .
Further, to specify the best predictive cut-off for the most important predictor(s) and confirm predictive power of the final model, we further applied a curvilinear fitting procedure to define logistic regression parameters, a receiving operator characteristics (ROC) curve analysis ( Figure 3 ) and stratified cumulative 12-month KaplanMeier survival analysis with 95% confidence intervals, and log-rank testing for significant differences (not shown).
Results
There were 8 cerebrovascular events (14.8%) over the 12-month follow-up period -these comprised of 7 strokes (6 -ischaemic, 1 -haemorrhagic) and 1 transient ischaemic attack (TIA). The one-year risk for CVE after MIS was ≈15% (95%CI 7.1±27.7%). No deaths, vascular or other, were observed during the study period.
Summary data on the most important parameters at baseline are given in Table 1 . The patients with CV event were only men (p<0.045) but they had differed by neither higher systolic blood pressure at Day 30 (p=0.253), higher fibrinogen (p=0.150), lower BMI (p=0.407) nor low HDL cholesterol (0.086) from the patients without CV events. Nor differences by diabetes status (p=0.99) or education grade level (p=0.682) was observed. The former differed only by the type of MIS onset (p=0.006) and diastolic blood pressure at Day 30 (p=0.033). At multivariate stepwise backward regression analysis (considering 5 potential predictors consisting or known risk factors or other variables from Table 1 that were significantly or marginally associated with CVE at univariate analysis), only the type of MIS onset and DPB at Day 30 were significantly and independently associated with the risk of secondary CVE (79.6% model accuracy, p model =0.0015, Table 2 ). Thus, we found that an increase of DBP with 1 mmHg was associated with an 8% higher risk of CVE [adjusted OR=1.08 (95%CI 1.004±1.158)]. However, because of only 8 CV events, direct interpretation of these results should be done with caution.
Notably, among the above potential predictors, both ANN models (Figure 2A and 2B Diastolic blood pressure cut-off predicts major cerebrovascular events after minor ischaemic stroke: a post-hoc modelling study Figure 3A ). The DBP performance to predict CV event was validated by significant area under the curve (AUC) of about 80% (ROC AUC =0.79, 95%CI 0.60±0.99, p=0.009) and a novel cut-off predictive value in DBP of 95 mmHg for CV events has been chosen (sensitivity>87%, specificity>69%, Figure 3B ). This particular critical value in MIS patients was confirmed by the significant difference between the stratified cumulative survival curves above and below the cut-off (7 vs. 1 CV events, p log-rank =0.0103, not shown).
Discussion
The current post-hoc analysis of a unique prospective 12-month study cohort of MIS patients from Bulgaria presented novel results on DBP as one of the most important risk factors for secondary CV events. To note, these two important and independent predictors have been revealed on the background of well-known and clinically defined conventional modifiable and non-modifiable cerebrovascular risk factors as arterial hypertension, advanced age, smoking, hyperlipidaemia, co-morbid heart diseases, diabetes, overweight, etc. Our clinical data indicated that the most frequent risk factor observed was the involvement of the middle cerebral artery while the duration of neurological deficit in 48 patients (88.9%) lasted up to 3 weeks after MIS [9] . The distribution of the known risk factors for cerebrovascular diseases in our study coincides with that as given in other publications as not only being peculiar for Bulgarian patients with MIS [15, 16] but also being typical for MIS patients from other countries [17, 18] .
Our current study not only confirms the earlier results [8, 9] that the increased risk for stroke after MIS is of multifactorial nature and strongly depends on the type of MIS onset and diastolic blood pressure (in particular, The larger area between the ROC curve and the diagonal line reflects the higher degree with which the DBP parameter shows a predictive benefit. X-axis, 1-Specificity; Y-axis, Sensitivity. Both estimates are expressed as a proportion of patients without or with CV events (i.e., from 0.00 to 1.00).
MIS, minor ischaemic stroke; CV, cerebrovascular. Diastolic blood pressure cut-off predicts major cerebrovascular events after minor ischaemic stroke: a post-hoc modelling study at day 30 after MIS) but it also explores more in depth these relationships by both conventional statistics and probabilistic models. As of note, there is a predominant frequency of ischaemic secondary CVE after MIS (6 out of 8) which is close to the frequency of lacunar strokes of about 10-12% as reported by other studies [19, 20] . As postulated earlier, the type of the new CVE after a lacunar stroke is also a lacunar stroke [21, 22] as about one-half of the new events are leading to severe neurological deficit -7 out of 8 secondary CVE in our MIS patients had a predominantly coinciding localisation that led to advanced neurological deficit. The potentially prevalent atherosclerotic patterns in our MIS patients and the related vascular damage can be considered as modulators not only for increased secondary risk of CV events but also for the acute onset in MIS as well as increased DBP (8% higher risk with every increase by 1 mmHg). Our multifactorial modelling revealed an interchanging relative but independent importance of both predictors as revealed by conventional statistics (with limitations) and probabilistic ANN modelling ( Table 2 and Figure 2 ). This may clearly indicate the need for a continuous monitoring of DBP in patients with acute onset of MIS within practical implications of the newly establish cut-off of 95 mmHg for a closer and more stringent monitoring of the dynamically increasing risk for secondary CV events in such patients.
Our study has limitations since the study cohort may have a higher baseline risk than other populations, with high population prevalence of cerebro-and cardiovascular risk factors (e.g., prior cardiac disease, hypertension, etc.). All our patients were aged >40 years and their risk may be higher than other, lowerrisk populations. We realize that the number of cases enrolled in our study is limited and it is clear that a larger sample would increase the study power. However, because most strokes occur in patients >40 years of age, our results are likely to be generalizable. It is also possible that there may be a small number of non-hospitalized stroke cases that were not reported, thus, having slightly higher risk estimates . Notably, the current analysis indicated that the risk of nonfatal stroke is very likely to remain high over a long term after MIS as also noted in our recent work on dynamic incidence patters over a 3-year follow-up [7] . Therefore, prevention strategies focused on secondary stroke prevention are warranted; these may become even more effective if the early increased risk defined by an acute MIS onset and increased DBP is predicted and captured by our novel approach. For instance, aggressive blood pressure control, even in patients without overt hypertension, benefited patients in the PROGRESS trial [23] . There may also be anti-platelet agents, such as dipyridamole, that are effective in stroke prevention [24] .
